Continuum Advisory’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,668
| Closed | -$12.5K | – | 517 |
|
|
2025
Q1 | $12.5K | Buy |
1,668
+470
| +39% | +$3.53K | ﹤0.01% | 934 |
|
|
2024
Q4 | $9.01K | Sell |
1,198
-91
| -7% | -$684 | ﹤0.01% | 1016 |
|
|
2024
Q3 | $9.6K | Buy |
1,289
+91
| +8% | +$678 | ﹤0.01% | 1004 |
|
|
2024
Q2 | $7.4K | Hold |
1,198
| – | – | ﹤0.01% | 1015 |
|
|
2024
Q1 | $6.4K | Buy |
+1,198
| New | +$6.4K | ﹤0.01% | 1031 |
|